Google DeepMind announced Wednesday that its latest artificial intelligence system, AlphaFold 3, can predict the three-dimensional structure of virtually any biological molecule with unprecedented accuracy.

The breakthrough builds on the company's Nobel Prize-winning work on protein structure prediction, extending its capabilities to DNA, RNA, and drug-like molecules.

Implications for Medicine

"This is a leap forward for biological research," said Demis Hassabis, DeepMind's CEO. "Understanding how molecules interact is fundamental to developing new medicines."

Pharmaceutical companies have already begun using the technology to identify potential drug candidates for diseases ranging from cancer to Alzheimer's.

Open Access

DeepMind said it will make the research available to the scientific community, continuing its practice of sharing foundational AI breakthroughs.